Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.

MLA

Lee, Junekyung, et al. “Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.” Archives of Physical Medicine & Rehabilitation, vol. 101, no. 9, Sept. 2020, pp. 1485–96. EBSCOhost, https://doi.org/10.1016/j.apmr.2020.03.025.

APA

Lee, J., Chun, M. H., Ko, Y. J., Lee, S.-U., Kim, D. Y., Paik, N.-J., Kwon, B. S., & Park, Y. G. (2020). Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial. Archives of Physical Medicine & Rehabilitation, 101(9), 1485–1496. https://doi.org/10.1016/j.apmr.2020.03.025

Chicago

Lee, Junekyung, Min Ho Chun, Young Jin Ko, Shi-Uk Lee, Deog Young Kim, Nam-Jong Paik, Bum Sun Kwon, and Yoon Ghil Park. 2020. “Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.” Archives of Physical Medicine & Rehabilitation 101 (9): 1485–96. doi:10.1016/j.apmr.2020.03.025.